Navigation Links
AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Date:4/24/2008

WESTCHESTER, Ill., April 24 /PRNewswire/ -- AANS/CNS Section on Tumors and BrainLAB today announced the winner of the 2008 International Research Fellowship. Xiang Wang, MD, from the People's Republic of China, was awarded the fellowship for his proposal, "The Trafficking of Bone Marrow Derived Mesenchymal Stem Cells in Brain Tumor Angiogenesis and Stromal Development."

Dr. Wang will receive a $50,000 stipend to conduct research in his proposed field of study in the laboratory of Victor C-K Tse, MD, PhD, Associate Professor of Neurosurgery at Stanford University. The program will last for one year.

Started in 2006, the fellowship enables international neurosurgeons or graduating residents from outside the United States and Canada to perform clinical, translational or basic research in the field of neurosurgical oncology in a clinical or laboratory setting within the United States. Applications for the 2008 fellowship were received from Brazil, China, Honduras, India, Iran, Italy, Japan, Nigeria and Turkey.

The goal of the fellowship is to foster collaborative research between the U.S. and international neurosurgeons. BrainLAB funds the fellowship through an educational grant and the program receives further support from dedicated U.S. institutions (Investigators), which provide the space and supplies for the applicant during the study period. The winner of the 2007 fellowship, Kazuhiko Kurozumi, MD, from Okayama, Japan, is currently at The Ohio State University laboratory of E. Antonio Chiocca, MD, PhD.

Dr. Kurozumi recently had his paper, "Effect of Tumor Micro-environment Modulation on the Efficacy of Oncolytic Virus Therapy," published in The Journal of the National Cancer Institute (JNCI 99:1768-81, 2007). His fellowship will be completed in June 2008.

According to Michael McDermott, MD, chairman of the AANS/CNS Section on Tumors, "Partnering with BrainLAB for this fellowship is a valuable contribution to the field of ne
'/>"/>

SOURCE BrainLAB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
2. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
3. Inverness Medical Innovations Announces First Quarter 2008 Results
4. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
5. United Therapeutics to Announce First Quarter 2008 Financial Results Before Market Open on Thursday, May 1, 2008
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
8. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
9. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
10. Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
11. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)... Gabon, December 2 , ... and Heritage" , Coinciding ... 2010 the,Gabonese Republic is hosting an international conference ... resources in Africa. The,conference will be attended by ...
(Date:12/2/2009)... TechConnect World, an event bringing together the ... cleantech, nanotech, biotech and MEMS, announced the December ... ,, Now in its 14th year, TechConnect World, ... Institute (NSTI), and the Clean Technology and Sustainable ...
(Date:12/2/2009)... S*BIO Pte Ltd today announced data presentations on ... Society of Hematology 51st Annual Meeting and Exposition in ... clinical results from the Phase 1 dose-escalation trial of ... in dose levels ranging from 100 to 600 mg. ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
... Marketing and Sales; Susan Koppy ... President, Corporate Development, PT. RICHMOND, Calif., July 2 ... the position of,Vice President, Marketing and Sales and Susan Koppy ... and Ms. Koppy will report,to President & Chief Executive Officer ...
... manufactured from bone marrow; SV Life ... LAKE CITY and HAMBURG, Germany, July 2 AlloCure,Inc., ... therapies,for the treatment of acute kidney injury, today announced ... was led by SV Life Sciences with Novo,A/S joining ...
... Aureus Pharma, a leading provider of,knowledge management solutions ... today that the Aureus Pharma 2008 User Symposium ... 24th., This symposium follows last year,s highly ... Aureus, pharmaceutical and biotech customers,from both Europe and ...
Other Biology Technology:Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2
(Date:12/3/2009)... social snubbing? Your genetics, not your friends, may be at ... opioids, relieve not only physical pain, but also some forms ... of 1000 Biology member Markus Heilig shows that small genetic ... the intensity of people,s responses to social rejection. , ...
(Date:12/3/2009)... of scientists from the U.S. Department of Energy,s (DOE) ... of Science has made a major step in understanding ... is necessary to carry out important biological processes. The ... Nature Structural & Molecular Biology , confirms that ...
(Date:12/2/2009)... results strengthen the evidence that people who smoke cigarettes ... risk for developing colorectal cancer, even after adjusting for ... reason not to smoke, or to quit as soon ... M.S., vice president emeritus, epidemiology and surveillance research at ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 1Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 3HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Kendle to Present at UBS Global Life Sciences Conference 14090 1Kendle to Present at UBS Global Life Sciences Conference 14090 2
... from what a runner might take on a jog, ... make life more comfortable for cattle. , A jogger,s ... pedometer are a few of the tools K-State researchers ... routine procedures, castration and dehorning. , Hans Coetzee, assistant ...
... that are embedded in their cell walls. For the ... the plasmodesmata are lifelines, allowing nutrients and genetic instructions ... cues trigger changes in the structure of the tiny ... The genes and molecular pathways of the plant cell ...
... University March 2-3 to discuss engineering solutions to major ... to education and energy. , The summit is in ... http://www.engineeringchallenges.org/ ) issued last year by the National Academy ... will play a critical part in resolving major societal ...
Other Biology News:Veterinarians developing model to help producers, vets make cattle more comfortable 2Veterinarians developing model to help producers, vets make cattle more comfortable 3CSHL researchers identify gene that helps plant cells keep communication channels open 2CSHL researchers identify gene that helps plant cells keep communication channels open 3Duke forum to address global engineering problems 2